Welcome to chemicalbook!
Chinese English Japanese Germany Korea
010-86108875
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Toceranib
356068-94-5

Toceranib synthesis

5synthesis methods
1-(2-Aminoethyl)pyrrolidine

7154-73-6

5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid

356068-93-4

Toceranib

356068-94-5

General procedure: 5-((Z)-(5-fluoro-2-oxoindolidine-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (100 g) was dissolved in dimethylformamide (500 ml), and benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (221 g), N-(2-aminoethyl)pyrrole (45.6 g) and triethylamine (93 ml). The reaction mixture was stirred at room temperature for 2 hours. After completion of the reaction, the solid product was collected by vacuum filtration and washed with ethanol. The resulting solid was slurried in ethanol (500 ml) by stirring at 64 °C for 1 h and subsequently cooled to room temperature. The solid was again collected by vacuum filtration, washed with ethanol and dried under vacuum to afford (Z)-5-((5-fluoro-2-oxoindol-3-ylidene)methyl)-2,4-dimethyl-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrole-3-carboxamide (101.5 g, 77% yield). The product was characterized by 1H-NMR (dimethylsulfoxide-d6): δ 1.60 (m, 4H, 2xCH2), 2.40,2.44 (2xs, 6H, 2xCH3), 2.50 (m, 4H, 2xCH2), 2.57,3.35 (2xm, 4H, 2xCH2), 7.53,7.70,7.73,7.76 (4 xm. 4H, aromatic and vinyl), 10.88 (s, 1H, CONH), 13.67 (s, 1H, pyrrole NH). Mass spectral analysis showed m/z 396 [M + 1].

7154-73-6 Synthesis
1-(2-Aminoethyl)pyrrolidine

7154-73-6
225 suppliers
$15.00/1g

356068-93-4 Synthesis
5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid

356068-93-4
142 suppliers
$45.00/25mg

-

Yield: 77%

Reaction Conditions:

with (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate;triethylamine in DMF (N,N-dimethyl-formamide) at 20; for 2 h;

Steps:


5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (100 g) and dimethylformamide (500 ml) were stirred and benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (221 g), 1-(2-aminoethyl) pyrrolidine (45.6 g) and triethylamine (93 ml) were added. The mixture was stirred for 2 hours at ambient temperature. The solid product was collected by vacuum filtration and washed with ethanol. The solids were slurry-washed by stirring in ethanol (500 ml) for one hour at 64 C and cooled to room temperature. The solids were collected by vacuum filtration, washed with ethanol, and dried under vacuum to give 5-[5-fluoro-2-oxo-1,2-dihydro-indol- (3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide (101.5 g, 77 % yield). 1H-NMR (dimethylsulfoxide-d6) δ 1.60 (m, 4H, 2xCH2), 2.40, 2.44 (2xs, 6H, 2xCH3), 2.50 (m, 4H, 2xCH2), 2.57, 3.35 (2xm, 4H, 2XCH2), 7.53, 7.70, 7.73, 7.76 (4xm, 4H, aromatic and vinyl), 10.88 (s, 1H, CONH), 13.67 (s, 1H, pyrrole NH). MS m/z 396 [M+1].

References:

PHARMACIA & UPJOHN COMPANY WO2004/76410, 2004, A2 Location in patent:Page 12

Toceranib Related Search: